Authorizing Legislation (PDF- 497 KB)
The Vaccine Injury Compensation Trust Fund provides funding for the National Vaccine Injury Compensation Program to compensate vaccine-related injury or death claims for covered vaccines administered on or after October 1, 1988.
The Trust Fund is funded by a $0.75 excise tax on vaccines recommended by the Centers for Disease Control and Prevention for routine administration to children. The excise tax is imposed on each dose (disease that is prevented) of a vaccine. Trivalent influenza vaccine for example, is taxed $0.75 because it prevents one disease; measles-mumps-rubella vaccine, which prevents three diseases, is taxed $2.25.
The Department of Treasury collects the excise taxes and manages the Fund’s investments. Vaccine Injury Compensation Trust Fund Monthly Reports
National Vaccine Injury Compensation Program (VICP)
Parklawn Building, Room 11C-26
5600 Fishers Lane
Rockville, Maryland 20857
Office of Communications
Health Resources and Services Administration
5600 Fishers Lane 20857
Rockville, MD 20857
Contacting the Court for More Information about Filing a Claim
U.S. Court of Federal Claims
717 Madison Place, N.W.
Washington, DC 20005
Obtaining a List of Lawyers Who File VICP Claims
A list of vaccine attorneys can be obtained by accessing the Court's website or your State or local bar association.
Vaccine Adverse Event Reporting System (VAERS)
VAERS is a Federal program used to report injuries or illnesses that occur after a vaccine is given. Filing a VAERS report is not the same as filing a claim with the VICP. VAERS and the VICP are different programs. For more information about VAERS, call 1-800-822-7967 or visit the VAERS website.
Revisions to the Vaccine Injury Table were released in a Notice of Proposed Rulemaking (NPRM) published in the Federal Register on July 29, 2015.
The measles, mumps, and rubella vaccine (MMR) has a long record of safety. Serious adverse reactions from MMR are rare.
The vaccine protects children against dangerous, even deadly diseases and should be given as recommended, when a child is between 12 through 15 months of age. If you wait to give it later, your child could get measles, mumps, and/or rubella, all of which remain a threat in the U.S. Learn more: Understanding MMR Vaccine Safety (PDF - 494 KB)
What You Need to Know about the National Vaccine Injury Compensation Program - English booklet (PDF - 1.36 MB)
Lo que usted necesita saber sobre el Programa Nacional de Compensación por Daños Derivados de Vacunas - Spanish booklet (PDF - 1.39 MB)
Childhood Immunization Information for Consumers (National Library of Medicine MEDLINEPlus)
If you have additional questions, call:
Countermeasures Injury Compensation Program provides compensation to individuals for serious physical injuries or deaths from pandemic, epidemic, or security countermeasures, such as the 2009 pandemic H1N1 influenza vaccine (swine flu vaccine), Tamiflu, Relenza or Peramivir, identified in declarations issued by the Secretary of the U.S. Department of Health and Human Services.